Found 49 matching trials
GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma
PHASE2Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors i...
Location
Cancer Center, Sun Yat-sen University
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer
PHASE2The purpose of this study is to determine whether combining of radiofrequen...
Status
Active Not Recruiting
Location
Multiple Locations
Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer
PHASE2This randomized, multicenter,open-label phase II/III study is to evaluate t...
Location
Tianjin Medical University Cancer Institute and Hospital
Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
PHASE1It is a non-randomized pilot study.The allocation will be determined by pat...
Location
Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital
Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
PHASE2This is a prospective, randomized, open, multicenter phase โ
ก study to evalu...
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma
PHASE2The purpose of this study is to determine whether combining of radiofrequen...
Status
Active Not Recruiting
Location
Multiple Locations
The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
PHASE2The purpose of this study is to evaluate the safety and efficacy of Apatini...
Status
Active Not Recruiting
Location
Multiple Locations
Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection
EARLY_PHASE1This study tests whether it is safe and feasible to give patients with hepa...
Location
Liver Transplant and Surgery Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
PHASE2The purpose of this study is to show if vaccination with autologous dendrit...
Location
Multiple Locations
Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC
PHASE1This prospective, unicentric, open-labe phase I study is to evaluate the ef...
Location
Tianjin Medical University Cancer Institute and Hospital